Introduction
Over the last few years it has been recognized that In 1995,6 we reported the results of a voluntary, the prevalence of HIV infection is much higher in anonymous seroprevalence survey of hepatitis C prisoners in Western countries than in the communitserology in a male medium-security Canadian federal ies from which they come.1,2 More recently, it has penitentiary (prisoners sent to federal penitentiaries also been recognized that the prevalence of hepatitis have all been sentenced to two or more years in C in prisons is also much higher in comparison to prison). We had conducted a survey of HIV serology the general population,3-6 and is related to the high in the same prison the previous year.12 Of the total number of drug users among the incarcerated. These of 592 prisoners, 408 volunteered a blood sample individuals not only bring to prison diseases such as and of these 27% tested positive for hepatitis C and HIV and hepatitis which they have acquired on the 1% positive for HIV. At the time of the hepatitis C street, but are likely to continue the risk behaviour study, we had administered a simple questionnaire such as sharing of injection equipment which got regarding risk behaviour which was unlinked to the them infected in the first place.7,8 Indeed, the unavailblood samples, and 12% of inmates admitted to ability of clean injection equipment in prisons in injecting drugs in prison at some time although not most Western countries results in small numbers of necessarily during their current sentence. needles and syringes being shared by many indiThis paper reports a repeat survey of hepatitis C viduals, and increases the chances that those not already infected will eventually become so. [9] [10] [11] and HIV serology carried out in 1998 in the same penitentiary. On this occasion a risk behaviour was made clear to prisoners that the whole process was voluntary and that individuals donating a blood questionnaire was linked to the blood sample and included questions on drug use, injection practices sample were not obliged to complete the questionnaire. and tattooing.
Results were distributed to participants 4 weeks later, and the population was given the overall results.
Methods
Blood samples were sent to the Public Health Laboratory at Kingston for testing. Seropositivity was Ethical approval for the study was obtained from the Queen's University Faculty of Medicine Ethics established by detection of antibodies to hepatitis C (anti-HCV) and to HIV in serum. Initial screening Review Board.
The study format, with the exception of the was carried out using the micro-particle enzyme immunoassay (MEIA), the Abbott AXSYM System: questionnaire was essentially the same as for our previous prison studies. 5, 6, 12 The nature of the study HCV version 3 for anti HCV, and HIV-1/HIV-2 for HIV antibody detection. Samples positive on the and the methodology was discussed with the prison inmate committee and the Lifers Group (a group initial screen were repeated and confirmed by immunoblotting using the LIATEK III (Organon Teknika) representing prisoners serving life sentences) and an acceptable format was agreed upon both for the and NOVA-PATH-BIORAD-HIV 1 (Bio-Rad Laboratories) for hepatitis C and HIV, respectively. conduct of the study and the nature of the questionnaire. An educational programme around hepatitis C Samples with 'indeterminate' results were further tested using a third-generation HCV 3.0 Sanofi or and HIV and the reasons for the study were offered on a voluntary basis to the whole prison population Biochem Immunosystems Detect HIV version 1 ELISA. in a group format.
A video which had been made for the previous Univariate analysis was used to determine the association between reported risk factors and hepatstudies by a prisoner film group (Big House Productions) was updated and shown several times itis C status. x2 tests were used to determine the statistical significance of the association, and odds on the in-house prison television circuit.
A one-page questionnaire (Appendix 1) included ratios were generated to estimate the magnitude of the association. Logistic regression was used to detailed questions on drug use both before and during incarceration as well as asking about injection control for confounding. practices and tattooing. There were no questions about sexual practices as discussions with prisoner representatives indicated such questions would be Results unpopular and might result in refusal to complete the questionnaire. At the request of prisoner represOf the 520 prisoners, 355 (68%) volunteered a blood sample (similar to the 69% who had volunteered for entatives, a question was included on in-prison dental treatment. Prisoners were also asked how long the 1995 hepatitis C study in the same prison6); only 5 of those 355 did not complete a questionnaire. they had been in prison serving their current sentence.
Not all prisoners answered all of the questions (see Appendix 1). Blood samples were collected in a single tube and labelled with a number unique to the individual.
Forty-four percent of prisoners had served less than 2 years of their current sentence, 20% had The same number was applied to the questionnaire which the prisoner had completed at the time of served between 2 and 4 years and 37% had been in for more than 4 years, with 6% having been in donating blood. A third label with the same number was given to the prisoner to present in order to for over 15 years. One hundred and seventeen (33%) tested positive obtain his results.
Each prisoner's test results were placed in a sealed for hepatitis C and six (2%) tested positive for HIV: this compares to 28% who tested positive in the envelope with his number on the outside and envelopes were handed out in exchange for the appro-1995 study in the same prison6 and 1% who tested positive for HIV in 1994. priately numbered sticker by members of the study team who were available at the time and subLogistic regression was done using hepatitis C status as the dependant variable. After accounting sequently for post-test counselling.
The study was carried out over 2 days in March for potential confounding, the only variable still independently related to being hepatitis-C-positive 1998. Sections of the prison were shut down sequentially, and two four-person teams went around the was injecting drugs outside the prison ( p=0.0056).
Risk behaviours: 95/350 (27%) reported no risk ranges collecting blood from volunteers, each of whom was offered a questionnaire to complete. It behaviour and of these only 6% were hepatitis-C- Table 1 Results for hepatitis C testing in individuals with positive and none were HIV-positive. who had tested positive for hepatitis C but negative for HIV in the study developed a 'flu'-like illness 6
The majority of those who had been tattooed inside only had been tattooed during their current sentence.
weeks after the study and was found subsequently to be HIV-positive. Drug injectors were asked about bleach use, and there was no significant difference in hepatitis C were asked to complete a one-page questionnaire which was linked to the blood sample. This questionnaire asked about risk behaviour relating to drug use is due to increasing numbers of IV drug users being incarcerated and bringing their habit in with them. rates are being imported into the prisons, with the added risk of additional spread within institutions. Furthermore, those who shared injection equipment on the outside were likely to continue to do so in Reported rates of hepatitis C in i.v. drug users are much higher than rates of HIV, probably reflecting prison and another 27 had started sharing for the first time in prison. There was no apparent protective the higher transmission efficiency of hepatitis C. 24 It is unlikely that inclusion of questions regarding effect of regular bleach use against hepatitis C infection in the drug users.
sexual activity would have altered the results as studies which have included such questions have Tattooing does not emerge as an independent variable. The rate in those only tattooed in prison, usually found a low level of sexual activity in prison, probably in part due to a reluctance to divulge such where it is an illegal practice performed clandestinely and often with unsterile needles, is surprisingly low information.25 A number of measures has been proposed to at 5%, although the number is small (only 39 prisoners). This latter figure is of interest because an decrease the spread of blood-borne pathogens in prisons. These include provision of bleach and educational film about the health risks of tattooing had been made in this prison 2 years previously by condoms, drug rehabilitation, methadone programmes and provision of clean needles and syran inmate film unit (Big House Productions) and had involved all the known tattoo artists in the prison at inges. Many jurisdictions have adopted at least some of these measures, with some European countries that time. Tattooing has been recognized as a risk factor for transmission of hepatitis C inside prison. 13, 14 taking the lead in provision of clean needles and syringes.26 It would seem clear from our observations, The number of HIV positives (six) was too small to draw any useful conclusions, but five of the six that at least in Canada, the bulk of the problem is being imported into the prisons from the outside had a history of i.v. drug use, and this reflects the predominant transmission risk that we see in the with further transmission occurring within the prisons. Society needs to urgently consider some HIV-positive prisoners in the several federal penitentiaries in our region. It is of note that one prisoner alternatives to incarceration of i.v. drug users in an environment where drugs are readily available, who tested negative for HIV in the study developed a 'flu'-like illness 6 weeks later and seroconverted.
where drug rehabilitation programmes are poor or non-existent, where methadone is often not available, This man had been in prison for over 4 years and was a current i.v. drug user who had been sharing and where safe injection practices are often impossible. Clearly some offenses require removal of the equipment with an individual known to be HIVpositive. In-prison HIV seroconversions are reported individual from society, but a recently reported pilot scheme in Britain whereby drug users, many with a infrequently. 15 This prisoner had been sharing injection equipment with at least 10 other individuals, all history of multiple criminal offences, were directed into drug rehabilitation programmes, offers a conof whom subsequently tested negative for HIV.
Hepatitis C and HIV infection rates are high in structive alternative for many27 and offers significant monetary savings to society in the form of reduced prisons in the industrialized world and the rates reported here are similar to rates reported elsedrug related criminal activity. HIV is transmitted by i.v. drug use, although less where.2,4,11,16,17 These high infection rates seem to be due, in large part, to the high rates of incarceration efficiently than hepatitis C. The rising level of hepatitis C on the streets in Canada has been followed by of intravenous drug users.7,8,11,18-21 There has been concern in recent years about the transmission of a rising level of HIV. It is only a matter of time before the increased HIV rates appear in the prisons both hepatitis and HIV within prisons because of the concentration of IV drug users and the lack of facility in Canada, as they have already done in some other countries. It is important to recognize that although for safe injection practices.22 It would seem from this study that although much of the hepatitis C is there are harm reduction strategies which should be used within the prisons, the bulk of the problem is contracted outside the prisons, there are some who appear to have been infected by injecting for the on the streets, and that public policy should be directed at primary prevention and drug rehabilitation first time in prison and others who appear to have shared for the first time in prison.
programmes, as well as directing non-violent drugaddicted offenders into rehabilitation programmes as The rates of both hepatitis C and HIV are rising amongst street drug users in Canada. A recent study an alternative to incarceration. in Vancouver found a seroprevalence for hepatitis C antibody of 85% with an incidence density of 26.7 per hundred person years (D. Patrick, personal com-
